-
Repurposing Approved Drugs to Modulate DNA Repair in CRISPR
2026-05-13
This study systematically screens over 7,000 FDA-approved drugs to identify modulators of DNA double-strand break repair pathways in human iPSCs. The findings reveal new opportunities for precision genome editing and synthetic lethality strategies by pharmacologically influencing NHEJ, MMEJ, and HDR repair outcomes.
-
Practical Use of HyperPFU™ High-Fidelity DNA Polymerase in P
2026-05-13
HyperPFU™ high-fidelity DNA polymerase is designed for robust PCR amplification of long, GC-rich, or otherwise difficult DNA templates where standard enzymes fail, ensuring high sequence fidelity and blunt-ended products. It should be prioritized for applications like cloning, sequencing, or high-throughput PCR needing highly accurate replication, but is not suitable for workflows requiring 3'-A overhangs or sticky ends.
-
Caspase-3 Fluorometric Assay Kit: Precision Apoptosis Assays
2026-05-12
The Caspase-3 Fluorometric Assay Kit empowers researchers to quantify apoptosis with speed and sensitivity, streamlining DEVD-dependent caspase activity measurement workflows. Advanced troubleshooting and protocol refinements enable robust, reproducible results for oncology, neurodegeneration, and beyond.
-
Cy5-UTP: Illuminating Stress Granule Biology in RNA Virus Re
2026-05-12
Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) advances RNA virus research by enabling precise fluorescent RNA labeling for stress granule and innate immunity studies. This in-depth analysis bridges molecular tools with the latest findings in antiviral cellular mechanisms.
-
HyperPFU™ High-Fidelity DNA Polymerase: Technical Use and QC
2026-05-11
HyperPFU™ high-fidelity DNA polymerase addresses the challenge of accurate PCR amplification for long, GC-rich, or otherwise difficult DNA templates, where standard enzymes often fail due to low fidelity or poor processivity. It should be used in applications requiring blunt-ended, high-fidelity PCR products, and is not suitable for protocols dependent on 3'-A overhangs or sticky-end ligations.
-
AEBSF.HCl in Lysosomal Protease Regulation: Beyond Amyloid R
2026-05-11
Explore how AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) uniquely enables precise modulation of lysosomal serine proteases in advanced cell death models. This article offers a deeper, cross-disciplinary view that extends beyond conventional protease inhibition applications.
-
MLKL Polymerization, Lysosomal Permeabilization, and Catheps
2026-05-10
This study elucidates how MLKL polymerization on lysosomal membranes induces lysosomal membrane permeabilization (LMP), resulting in the release of cathepsin B and subsequent necroptotic cell death. The work demonstrates that chemical inhibition or knockdown of cathepsin B confers protection against necroptosis, providing mechanistic insight and a path for targeted experimental intervention.
-
Decoding Apoptosis: Caspase-3 Assays for Translational Impac
2026-05-09
This thought-leadership article explores how DEVD-dependent caspase-3 activity detection, exemplified by the Caspase-3 Fluorometric Assay Kit, is transforming apoptosis and pyroptosis research. By connecting mechanistic advances—such as the synergy between hyperthermia and cisplatin in cancer cell death—to strategic decisions in translational research, this piece offers nuanced protocol guidance, comparative analysis, and future-facing outlooks, all grounded in current literature and workflow realities.
-
Cy5-UTP for RNA Labeling: Advanced Workflows & Troubleshooti
2026-05-08
Cy5-UTP (Cyanine 5-UTP) transforms RNA probe synthesis with direct, high-sensitivity fluorescent labeling for in vitro transcription. This article delivers actionable protocols, real-world troubleshooting, and evidence-based optimization—empowering researchers to excel in applications from FISH to nanoparticle tracking.
-
Tubastatin A: HDAC6 Inhibitor Workflows for Translational Re
2026-05-08
Tubastatin A, a highly selective HDAC6 inhibitor, empowers researchers to dissect epigenetic regulation in cancer, neuroprotection, and inflammation. This guide delivers protocol optimizations, troubleshooting insights, and real-world assay enhancements for robust, reproducible results.
-
Structural Insights into CD38 CAR Affinity Tuning for Safer
2026-05-07
This study elucidates the molecular interactions between CD38-targeting CAR binders and their antigen, revealing distinct epitope engagement and mechanisms of enzymatic inhibition. The findings demonstrate how rational affinity tuning of CAR constructs can enhance tumor selectivity and minimize fratricide, informing the next generation of safer and more effective CD38-targeted immunotherapies.
-
Pentoxifylline Modulates Neonatal Monocyte Hyperinflammation
2026-05-07
Schüller et al. provide the first detailed in vitro characterization of pentoxifylline’s (PTX) anti-inflammatory effects on LPS-stimulated monocytes from preterm and term neonates versus adults. Their findings reveal age-dependent, dose-responsive modulation of key inflammatory markers and TLR4 signaling, with significant implications for translational neonatal sepsis therapy.
-
Exemestane in Translational Oncology: Beyond Aromatase Inhib
2026-05-06
Explore how Exemestane, a leading steroidal aromatase inhibitor, advances breast cancer research by enabling translational precision in hormone pathway studies. This article reveals unique, practical strategies and new assay insights unavailable elsewhere.
-
MLKL Polymerization Drives Lysosomal Permeabilization in Nec
2026-05-06
This study uncovers how polymerized MLKL translocates to lysosomal membranes, inducing permeabilization that releases cathepsin B and drives necroptosis. These findings clarify a key step in regulated cell death, offering new avenues for dissecting lysosomal enzyme involvement in inflammation and tissue injury.
-
MLKL Polymerization Drives Lysosomal Permeabilization in Nec
2026-05-05
This study uncovers how MLKL polymerization at lysosomal membranes triggers lysosomal membrane permeabilization (LMP), leading to necroptosis via cathepsin B release and activity. These insights advance understanding of regulated cell death and highlight the functional significance of lysosomal protease inhibition in cell death assays.